In the CNS, ghrelin stimulates appetite by binding to GHS-R1a receptors located in brain regions such as the ARC, PVN, and DMN [29] [30]
May modulate inflammatory pathways May reduce risk of cognitive decline May support cardiovascular health May improve mitochondrial function and oxidative stress Low doses may reduce side effects Microdosing GLP-1 Benefits Supports Longevity May activate biological pathways that extend GLP-1 benefits beyond weight loss to enhance overall healthspan
In the Phase 2 obesity trial, which followed adults with obesity or overweight for 48 weeks, the average reductions in body weight were striking: To put that in perspective, at the 12 mg dose, more than eight in ten participants lost at least 15% of their starting body weight
Body changes: Track your body weight, changes in appetite or cravings, any episodes of nausea or vomiting, and your calorie intake